微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 50.23% | 13.12% | 3.37% | 75/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 48.59% | -1.57% | 1.17% | 77/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 48.03% | -1.53% | 2.69% | 79/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 46.77% | -2.1% | 5.32% | 82/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 44.4% | -5.76% | -10.05% | 82/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 49.37% | 2.25% | 1.22% | 79/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 48.77% | 1.6% | 2.1% | 79/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 47.77% | -1.39% | 1.38% | 83/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 47.12% | -3.49% | -2.41% | 79/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 48.28% | -7.64% | 0.58% | 83/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 48% | -12.67% | -0.92% | 80/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 48.45% | -13.38% | -0.77% | 79/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 48.82% | 2% | -6.61% | 78/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 52.28% | -8.9% | -4.89% | 75/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 54.97% | 2% | -1.72% | 70/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 55.93% | -2.01% | -2.53% | 71/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 57.38% | 3.41% | 0.53% | 73/140 | 57.98% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 57.08% | 9.5% | 2.86% | 70/140 | 59.05% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 55.49% | 4.2% | 6.46% | 81/140 | 60.12% | 三友医疗 | 90.5% | 行业排名> |
| 2020-06-30 | 52.12% | -2.82% | -2.13% | 78/140 | 60.36% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 53.26% | 2% | -0.71% | 67/140 | 56.96% | 正海生物 | 90.78% | 行业排名> |
| 2019-06-30 | 53.64% | 2% | 2% | 42/140 | 57.93% | 正海生物 | 91.59% | 行业排名> |